Okada Emiko, Fujiishi Yohei, Yasutake Nobuyoshi, Ohyama Wakako
Yakult Central Institute for Microbiological Research, 1796 Yaho, Kunitachi-shi, Tokyo 186-8650, Japan.
Mutat Res. 2008 Nov 17;657(1):39-42. doi: 10.1016/j.mrgentox.2008.08.018. Epub 2008 Sep 2.
To assess the genotoxicity of chemicals on the stomach, we developed in vivo assays that can detect micronucleus induction and gene expression changes in epithelial cells of the glandular stomach in mice. Male BALB/c mice were orally given a single dose (100 mg/kg) of N-nitroso-N-methylurea (MNU) or N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) as stomach-targeted carcinogens. The glandular stomach was excised at 4h, 3 and 4 days after administration, and a single cell suspension of epithelial cells was prepared from the everted glandular stomach by EDTA treatment. For determination of micronucleus induction, gastric epithelial cells on days 3 and 4 after administration were fixed with 10% neutral-buffered formalin, stained with a combination of AO-DAPI, and analyzed under fluorescence microscopy. We also examined the induction of micronuclei in peripheral blood of these mice on days 2 and 3 after administration. Moreover, total RNA was extracted from gastric epithelial cells at 4h after administration, and p21 and plk2 expression was analyzed using a quantitative RT-PCR technique. 1) A significant increase of micronucleated cells was observed in the glandular stomach in mice treated with N-nitroso-N-methylurea (MNU) or N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) compared to mice treated with vehicle. 2) In peripheral blood, induction of micronuclei was observed in mice treated with MNU but not with MNNG. 3) p21 and plk2, which related to cell cycle arrest, were up-regulated in the glandular stomach in mice treated with MNU or MNNG compared to mice treated with vehicle. The present study showed that these assays using glandular stomach may help to evaluate the genotoxicity of chemicals after oral administration.
为了评估化学物质对胃的遗传毒性,我们开发了体内试验,该试验可检测小鼠腺胃上皮细胞中的微核诱导和基因表达变化。雄性BALB/c小鼠口服单剂量(100 mg/kg)的N-亚硝基-N-甲基脲(MNU)或N-甲基-N'-硝基-N-亚硝基胍(MNNG)作为靶向胃的致癌物。给药后4小时、3天和4天切除腺胃,通过EDTA处理从外翻的腺胃制备上皮细胞单细胞悬液。为了测定微核诱导情况,给药后第3天和第4天的胃上皮细胞用10%中性缓冲福尔马林固定,用AO-DAPI组合染色,并在荧光显微镜下分析。我们还在给药后第2天和第3天检查了这些小鼠外周血中的微核诱导情况。此外,给药后4小时从胃上皮细胞中提取总RNA,使用定量RT-PCR技术分析p21和plk2的表达。1)与给予赋形剂的小鼠相比,在用N-亚硝基-N-甲基脲(MNU)或N-甲基-N'-硝基-N-亚硝基胍(MNNG)处理的小鼠的腺胃中观察到微核化细胞显著增加。2)在外周血中,在用MNU处理的小鼠中观察到微核诱导,但在用MNNG处理的小鼠中未观察到。3)与给予赋形剂的小鼠相比,在用MNU或MNNG处理的小鼠的腺胃中,与细胞周期停滞相关的p21和plk2上调。本研究表明,这些使用腺胃的试验可能有助于评估口服给药后化学物质的遗传毒性。